2013
DOI: 10.1007/s00701-013-1771-4
|View full text |Cite
|
Sign up to set email alerts
|

Triple antiplatelet therapy with addition of cilostazol to aspirin and clopidogrel for Y-stent-assisted coil embolization of cerebral aneurysms

Abstract: Although the number of patients in the Y-stent group is small, this group had a significantly higher risk of thromboembolic complications. While our protocol of a routine dose of dual antiplatelet therapy may be sufficient for single stent therapy, our protocol of a routine dose of triple antiplatelet therapy for Y-stents may not prevent thromboembolic events. This suggests that evaluation of platelet function may be essential, especially for Y-stents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
2

Year Published

2013
2013
2016
2016

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 30 publications
0
11
0
2
Order By: Relevance
“…There are a number of reports on the differences between open-cell stents and closed-cell stents regarding wall apposition, hemodynamic effects, various configurations, such as Ystents, and recanalization rates [1,5,9,[13][14][15][16]. With regard to wall apposition, the Enterprise stent tends to cause malposition and kink in acutely curved vessels [2].…”
Section: Discussionmentioning
confidence: 99%
“…There are a number of reports on the differences between open-cell stents and closed-cell stents regarding wall apposition, hemodynamic effects, various configurations, such as Ystents, and recanalization rates [1,5,9,[13][14][15][16]. With regard to wall apposition, the Enterprise stent tends to cause malposition and kink in acutely curved vessels [2].…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, we performed stent-assisted endovascular techniques only if a good response to clopidogrel and ASA with values below the reference standards was ensured in the multiplate function test before all endovascular procedures. Kono et al 23 reported that even triple antiplatelet therapy may not prevent thromboembolic events and highlighted the importance of a platelet function evaluation before employment of intracranial stents. We report only one case of procedural embolism managed with the administration of tirofiban.…”
Section: Discussionmentioning
confidence: 99%
“…The rest of the 33 cases were excluded because of the following reasons: insufficient imaging quality for CFD (n = 2), retreatment cases (n = 5) [17], [18], post-operative in-stent stenosis (n = 1), post-operative in-stent occlusion (n = 1) [19], bifurcation aneurysms including aneurysms with small branches arising from the neck of aneurysms, such as those at the junction of the vertebral artery and the posterior inferior cerebellar artery, or ophthalmic artery aneurysms (n = 17) [20], and cavernous carotid artery aneurysms (n = 7) [21]. Cavernous carotid artery aneurysms were excluded because the internal carotid artery around the cavernous portion is partly covered with skull bones, which disturb changes in vascular geometry by stent placement.…”
Section: Methodsmentioning
confidence: 99%